Home / Coagulation Factor VIII / Belgium
BE ATC B02BD02 · updated 2 Nov 2026
Coagulation Factor VIII shortage in Belgium
Is there a Coagulation Factor VIII shortage in Belgium?
Yes. As of 2 Nov 2026, 2 Coagulation Factor VIII products are reported short in Belgium, the first since 7 Apr 2026. The company estimate for the return is 20 Nov 2026 (latest 31 Dec 2026). Main reason: other.
Also short in Italy, Spain, Austria, Switzerland, Czechia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | ReFacto AF 250 IU inj. sol. (pwdr. + solv.) i.v. pre-filled syr. 250 IU + 4 ml | Pfizer Europe MA | 7 Apr 2026 | 31 Dec 2026 | Other Other reason |
| BE | Jivi 1 000 IU inj. sol. (pwdr. + solv.) i.v. vial + pre-filled syr. 1000 IU + 2.5 ml | Bayer | 27 Jul 2026 | 20 Nov 2026 | Increased demand |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.